CL2008003730A1 - Derivado de metastina ; profarmaco de dicho derivado; producto farmaceutico de dicho derivado; uso de dicho derivado para tratar metastasis de cancer o crecimiento del cancer. - Google Patents

Derivado de metastina ; profarmaco de dicho derivado; producto farmaceutico de dicho derivado; uso de dicho derivado para tratar metastasis de cancer o crecimiento del cancer.

Info

Publication number: CL2008003730A1
Authority: CL; Chile
Prior art keywords: derivative; prodrug; metastin; pharmaceutical product; derived
Prior art date: 2004-06-25

Application number

CL2008003730A

Other languages

English (en)

Spanish (es)

Inventor

Kitada Chieko

Asami Taiji

Nishizawa Naoki

Original Assignee

Takeda Pharmaceuticals Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-06-25

Filing date

2008-12-15

Publication date

2009-05-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34971534&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2008003730(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-12-15 Application filed by Takeda Pharmaceuticals Co filed Critical Takeda Pharmaceuticals Co

2009-05-04 Publication of CL2008003730A1 publication Critical patent/CL2008003730A1/es

Links

KAHDONZOCXSKII-NJVVDGNHSA-N kisspeptin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H]1N(CCC1)C(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)O)C1=CN=CN1 KAHDONZOCXSKII-NJVVDGNHSA-N 0.000 title abstract 3
206010027476 Metastases Diseases 0.000 title abstract 2
206010028980 Neoplasm Diseases 0.000 title abstract 2
201000011510 cancer Diseases 0.000 title abstract 2
230000005907 cancer growth Effects 0.000 title abstract 2
230000009401 metastasis Effects 0.000 title abstract 2
239000000825 pharmaceutical preparation Substances 0.000 title abstract 2
229940127557 pharmaceutical product Drugs 0.000 title abstract 2
239000000651 prodrug Substances 0.000 title abstract 2
229940002612 prodrug Drugs 0.000 title abstract 2
102000013599 Kisspeptins Human genes 0.000 title 1
108010012048 Kisspeptins Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4703—Inhibitors; Suppressors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Hematology (AREA)
Reproductive Health (AREA)
Immunology (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Gynecology & Obstetrics (AREA)
Neurosurgery (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Emergency Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Zoology (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Pregnancy & Childbirth (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)

CL2008003730A 2004-06-25 2008-12-15 Derivado de metastina ; profarmaco de dicho derivado; producto farmaceutico de dicho derivado; uso de dicho derivado para tratar metastasis de cancer o crecimiento del cancer. CL2008003730A1 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2004187671		2004-06-25
JP2004363311		2004-12-15

Publications (1)

Publication Number	Publication Date
CL2008003730A1 true CL2008003730A1 (es)	2009-05-04

Family

ID=34971534

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2008003730A CL2008003730A1 (es)	2004-06-25	2008-12-15	Derivado de metastina ; profarmaco de dicho derivado; producto farmaceutico de dicho derivado; uso de dicho derivado para tratar metastasis de cancer o crecimiento del cancer.

Country Status (20)

Country	Link
US (2)	US7625869B2 (fr)
EP (2)	EP2113513B1 (fr)
JP (3)	JP4346650B2 (fr)
CN (2)	CN101845091A (fr)
AR (1)	AR049938A1 (fr)
AU (1)	AU2005257484A1 (fr)
BR (1)	BRPI0512397A (fr)
CA (1)	CA2571420A1 (fr)
CL (1)	CL2008003730A1 (fr)
CR (1)	CR8828A (fr)
IL (1)	IL179640A0 (fr)
MA (1)	MA28903B1 (fr)
MX (1)	MXPA06014206A (fr)
NO (1)	NO20065957L (fr)
NZ (1)	NZ552029A (fr)
PE (2)	PE20060371A1 (fr)
RU (1)	RU2006145886A (fr)
SG (1)	SG153865A1 (fr)
TW (1)	TW200607816A (fr)
WO (1)	WO2006001499A2 (fr)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003080149A2 (fr)	2002-03-20	2003-10-02	Mannkind Corporation	Appareil d'inhalation
CN1761680A (zh)	2002-12-26	2006-04-19	武田药品工业株式会社	肿瘤迁移抑制素衍生物及其用途
CA2518541C (fr)	2003-03-12	2013-05-21	Takeda Pharmaceutical Company Limited	Agents ameliorant la fonction gonadique
WO2005113147A2 (fr)	2004-04-08	2005-12-01	Biomatrica, Inc.	Integration du stockage et de la gestion d'echantillons pour les sciences de la vie
CA2571420A1 (fr)	2004-06-25	2006-01-05	Takeda Pharmaceutical Company Limited	Derives de metastine et leur utilisation
PL1786784T3 (pl)	2004-08-20	2011-04-29	Mannkind Corp	Kataliza syntezy diketopiperazyn
KR101644250B1 (ko)	2004-08-23	2016-07-29	맨카인드 코포레이션	약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
CN104324362B (zh)	2005-09-14	2018-04-24	曼金德公司	以提高活性试剂对结晶微粒表面的亲和力为基础的药物配制方法
US20090093615A1 (en) *	2005-12-22	2009-04-09	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
AR058584A1 (es)	2005-12-22	2008-02-13	Takeda Pharmaceutical	Derivados de metastina y uso de los mismos
US8404643B2 (en) *	2005-12-22	2013-03-26	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
IN2015DN00888A (fr)	2006-02-22	2015-07-10	Mannkind Corp
WO2007125619A1 (fr) *	2006-04-26	2007-11-08	Kyoto University	Nouveau compose ayant une activite agoniste de gpr54
ITMI20061607A1 (it)	2006-08-09	2008-02-10	Maria Vincenza Carriero	Peptidi con attivita farmacologica
JO3048B1 (ar) *	2006-10-25	2016-09-05	Takeda Pharmaceuticals Co	مشتقات متاستين واستخدامها
ZA200902452B (en) *	2006-10-25	2010-07-28	Takeda Pharmaceutical	Metastin derivatives and use thereof
EP2277900A4 (fr)	2008-04-24	2011-08-03	Takeda Pharmaceutical	Dérivé de métastine et son utilisation
EP2275433B1 (fr) *	2008-04-30	2017-06-07	Kyoto University	Dérivé de metastine et son utilisation
US8485180B2 (en)	2008-06-13	2013-07-16	Mannkind Corporation	Dry powder drug delivery system
ES2929343T3 (es)	2008-06-13	2022-11-28	Mannkind Corp	Inhalador de polvo seco accionado por aspiración para la administración de fármacos
KR101628410B1 (ko)	2008-06-20	2016-06-08	맨카인드 코포레이션	흡입 활동에 관한 실시간 프로파일링을 위한 대화형 장치 및 방법
LT2314609T (lt) *	2008-07-30	2017-04-10	Takeda Pharmaceutical Company Limited	Metastino darinys ir jo panaudojimas
JP2012513982A (ja)	2008-12-29	2012-06-21	武田薬品工業株式会社	癌の予防・治療剤
US8314106B2 (en)	2008-12-29	2012-11-20	Mannkind Corporation	Substituted diketopiperazine analogs for use as drug delivery agents
WO2010137022A1 (fr)	2009-05-27	2010-12-02	Yeda Research And Development Co. Ltd	Agonistes ou antagonistes de gpr54 utiles dans le traitement de maladies impliquant des anomalies du comportement
CN102665690A (zh)	2009-12-22	2012-09-12	武田药品工业株式会社	缓释制剂
IL223742A (en)	2010-06-21	2016-06-30	Mannkind Corp	A dry powder inhaler and preparation for it
WO2012018639A2 (fr)	2010-07-26	2012-02-09	Biomatrica, Inc.	Compositions de stabilisation d'adn, d'arn, de protéines salivaires et d'autres échantillons biologiques lors du transport et du stockage à températures ambiantes
EP2598660B1 (fr)	2010-07-26	2017-03-15	Biomatrica, INC.	Compositions de stabilisation d'adn, d'arn, de protéines dans le sang et d'autres échantillons biologiques lors du transport et du stockage à températures ambiantes
AU2012236150B2 (en)	2011-04-01	2016-03-31	Mannkind Corporation	Blister package for pharmaceutical cartridges
WO2012174472A1 (fr)	2011-06-17	2012-12-20	Mannkind Corporation	Microparticules de dicétopipérazine de capacité élevée
EP2755690B1 (fr)	2011-08-04	2020-04-01	Merck Sharp & Dohme B.V.	Conjugués du kisspeptide avec un pentasaccharide
BR112014009686A2 (pt)	2011-10-24	2018-08-07	Mannkind Corp	composição analgésica inalável, pó seco e método para tratar dor
CN104350064A (zh)	2012-03-14	2015-02-11	耶达研究及发展有限公司	修饰的吻素肽和其用途
CN104619369B (zh)	2012-07-12	2018-01-30	曼金德公司	干粉药物输送系统和方法
US9725703B2 (en)	2012-12-20	2017-08-08	Biomatrica, Inc.	Formulations and methods for stabilizing PCR reagents
WO2014119753A1 (fr) *	2013-01-31	2014-08-07	学校法人東京薬科大学	Peptide inhibiteur de la myostatine
MX375448B (es)	2013-07-18	2025-03-06	Mannkind Corp	Composiciones farmacéuticas en polvo seco estables al calor y métodos.
US10220069B2 (en) *	2014-01-22	2019-03-05	The Johns Hopkins University	Compositions and methods for treating diabetes
US10307464B2 (en)	2014-03-28	2019-06-04	Mannkind Corporation	Use of ultrarapid acting insulin
ES2786373T3 (es)	2014-06-10	2020-10-09	Biomatrica Inc	Estabilización de trombocitos a temperaturas ambiente
KR20250047404A (ko)	2015-12-08	2025-04-03	바이오매트리카 인코포레이티드	적혈구 침강 속도의 감소
TWI778979B (zh)	2016-09-30	2022-10-01	瑞士商麥歐文科學有限公司	治療女性不孕症之方法
CN109206481B (zh)	2017-07-05	2023-08-18	尚华医药科技(江西)有限公司	一种肽类化合物、其应用及含其的组合物
CN108752233B (zh) *	2018-07-18	2020-10-16	河北师范大学	小分子凝胶因子、凝胶材料及制备方法和应用
US20230159450A1 (en) *	2020-05-08	2023-05-25	The Feinstein Institutes For Medical Research	Dimers for use in synthesis of peptidomimetics
WO2025217074A1 (fr)	2024-04-08	2025-10-16	Radionetics Oncology, Inc.	Agents thérapeutiques ciblant le récepteur de la kisspeptine (kiss1r) et leurs utilisations

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1524747A (en) *	1976-05-11	1978-09-13	Ici Ltd	Polypeptide
FR2488253A1 (fr) *	1980-08-08	1982-02-12	Roques Bernard	Nouveaux peptides et leur application en therapeutique
IL74827A (en) *	1984-05-21	1989-06-30	Salk Inst For Biological Studi	Peptides active as gnrh antagonists and pharmaceutical compositions containing them
MX9100717A (es) *	1990-08-24	1992-04-01	Syntex Inc	Antagonistas de la bradiquinina
US5824784A (en)	1994-10-12	1998-10-20	Amgen Inc.	N-terminally chemically modified protein compositions and methods
CN1200114A (zh)	1995-10-19	1998-11-25	武田药品工业株式会社	作为gnrh拮抗剂的喹啉衍生物
JPH09169735A (ja)	1995-10-19	1997-06-30	Takeda Chem Ind Ltd	キノリン誘導体、その製造法および用途
JP2000510453A (ja)	1996-04-19	2000-08-15	ノボノルディスクアクティーゼルスカブ	成長ホルモン遊離特性を有する化合物
WO1998039448A2 (fr)	1997-03-07	1998-09-11	Human Genome Sciences, Inc.	186 nouvelles proteines secretees
JP4486187B2 (ja)	1998-10-27	2010-06-23	武田薬品工業株式会社	新規ｇ蛋白質共役型レセプター蛋白質、そのｄｎａおよびそのリガンド
US6528054B1 (en)	1998-12-28	2003-03-04	Corixa Corporation	Compositions and methods for the therapy and diagnosis of breast cancer
PL353057A1 (en)	1999-06-28	2003-10-06	Basf Aktiengesellschaft	Method for preventing tumoral growth
US6638906B1 (en)	1999-12-13	2003-10-28	Nobex Corporation	Amphiphilic polymers and polypeptide conjugates comprising same
JP2001231581A (ja) *	1999-12-17	2001-08-28	Takeda Chem Ind Ltd	ＫｉＳＳ−１ペプチドの製造法
CN1411509A (zh) *	1999-12-17	2003-04-16	武田药品工业株式会社	Kiss－1肽的制造方法
JP2004526401A (ja)	2000-03-29	2004-09-02	コリクサコーポレイション	肺癌の治療および診断のための組成物および方法
AU2001244609A1 (en)	2000-03-30	2001-10-15	Takeda Chemical Industries Ltd.	Novel protein, dna thereof and process for producing the same
US7834141B1 (en)	2000-03-31	2010-11-16	Theresa Siler-Khodr	Non-mammalian GnRH analogs and uses thereof in tumor cell growth regulation and cancer therapy
RU2311920C2 (ru)	2000-09-20	2007-12-10	Корикса Корпорейшн	Композиции и способы для лечения и диагностики рака легких
JP2003026601A (ja)	2000-11-29	2003-01-29	Takeda Chem Ind Ltd	医薬組成物およびその製造法
JP2002320496A (ja)	2001-02-26	2002-11-05	Takeda Chem Ind Ltd	新規マウス型ＫｉＳＳ−１レセプタータンパク質およびそのＤＮＡ
WO2002085399A1 (fr)	2001-04-20	2002-10-31	Takeda Chemical Industries, Ltd.	Preparations contenant un peptide
KR100599419B1 (ko) *	2001-05-17	2006-07-10	가부시키가이샤 시마즈세이사쿠쇼	펩티드의 제조법
US7112662B2 (en) *	2001-09-19	2006-09-26	Takeda Pharmaceutical Company Limited	Anti-metasin antibodies and their methods of use
WO2003060125A1 (fr)	2002-01-11	2003-07-24	Takeda Chemical Industries, Ltd.	Procede de production du peptide kiss-1
JP2003300906A (ja)	2002-04-12	2003-10-21	Daiichi Fine Chemical Co Ltd	がん転移抑制因子の安定化
JPWO2004035089A1 (ja) *	2002-10-09	2006-02-09	協和醗酵工業株式会社	ホルモン依存性癌の治療剤
DE60327344D1 (de)	2002-10-25	2009-06-04	Takeda Pharmaceutical	Gpr54 'knock-out' säugetiere und screening-verfahren, die sie verwenden
CN1761680A (zh) *	2002-12-26	2006-04-19	武田药品工业株式会社	肿瘤迁移抑制素衍生物及其用途
JP4804714B2 (ja)	2002-12-26	2011-11-02	武田薬品工業株式会社	メタスチン誘導体およびその用途
US6800611B2 (en) *	2003-01-06	2004-10-05	Takeda Chemical Industries, Ltd.	Metastin derivatives and their use
KR100595364B1 (ko)	2003-02-20	2006-07-03	재단법인 목암생명공학연구소	Ｌｋ8 단백질을 유효성분으로 포함하는 항암제
CA2518541C (fr)	2003-03-12	2013-05-21	Takeda Pharmaceutical Company Limited	Agents ameliorant la fonction gonadique
EP1464652A1 (fr)	2003-04-02	2004-10-06	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Agoniste et antagoniste du récepteur GPR54 utiles pour le traitement des maladies associées à la gonadotrophine
US20050002935A1 (en)	2003-04-17	2005-01-06	Vincent Ling	Use of B7-H3 as an immunoregulatory agent
EP1618384A2 (fr)	2003-04-28	2006-01-25	Wyeth	Procedes et compositions permettant de moduler le recepteur 54 couple a une proteine g
WO2004101747A2 (fr)	2003-05-07	2004-11-25	The General Hospital Corporation	Identification et utilisation de gpr54 et de ses ligands pour les troubles de la reproduction et la contraception
EP1633702B1 (fr)	2003-05-30	2008-07-02	Prozymex A/S	Inhibiteurs de protease
EP1688498B1 (fr)	2003-11-03	2011-03-09	Beijing Sunbio Biotech Co., Ltd.	Proteine de recombinaison anticancereuse, ses genes codant et ses utilisations
RU2333221C2 (ru)	2003-11-03	2008-09-10	Бейцзин Санбио Байотек Ко., Лтд.	Рекомбинантный белок, обладающий противораковым действием, кодирующий его ген и его применение
WO2005095973A2 (fr)	2004-03-25	2005-10-13	Bayer Healthcare Ag	Methodes diagnostiques et therapeutiques pour des maladies associees au recepteur 54 couple a la proteine g (gpr54)
JP2007533748A (ja)	2004-04-23	2007-11-22	アプライドリサーチシステムズエーアールエスホールディングナームロゼフェンノートシャップ	不妊症の処置のためのｇｐｃｒ５４リガンドの使用
CA2571420A1 (fr)	2004-06-25	2006-01-05	Takeda Pharmaceutical Company Limited	Derives de metastine et leur utilisation
WO2007084211A2 (fr)	2005-11-11	2007-07-26	The General Hospital Corporation	Utilisation de ligands du gpr54 pour le traitement de troubles de la reproduction, de troubles proliferatifs et pour la contraception
US8404643B2 (en) *	2005-12-22	2013-03-26	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
AR058584A1 (es) *	2005-12-22	2008-02-13	Takeda Pharmaceutical	Derivados de metastina y uso de los mismos
US20090099334A1 (en) *	2005-12-22	2009-04-16	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
US20090093615A1 (en) *	2005-12-22	2009-04-09	Takeda Pharmaceutical Company Limited	Metastin derivatives and use thereof
MX2008012055A (es)	2006-03-20	2008-10-02	Merck & Co Inc	Agonistas del receptor de neuromedina u y usos de los mismos.
US20100215637A1 (en) *	2006-03-28	2010-08-26	Biopharmica Ltd	Agent for the Treatment of Hormone-Dependent Disorders and Uses Thereof
JO3048B1 (ar)	2006-10-25	2016-09-05	Takeda Pharmaceuticals Co	مشتقات متاستين واستخدامها
CA2701612A1 (fr) *	2007-10-05	2009-04-09	Takeda Pharmaceutical Company Limited	Derive de neuromedine u
EP2277900A4 (fr)	2008-04-24	2011-08-03	Takeda Pharmaceutical	Dérivé de métastine et son utilisation
EP2340047A1 (fr)	2008-09-19	2011-07-06	Nektar Therapeutics	Conjugués de polymère de peptides kiss1

2005
- 2005-06-23 CA CA002571420A patent/CA2571420A1/fr not_active Abandoned
- 2005-06-23 PE PE2005000728A patent/PE20060371A1/es not_active Application Discontinuation
- 2005-06-23 RU RU2006145886/04A patent/RU2006145886A/ru not_active Application Discontinuation
- 2005-06-23 NZ NZ552029A patent/NZ552029A/en not_active IP Right Cessation
- 2005-06-23 SG SG200904360-5A patent/SG153865A1/en unknown
- 2005-06-23 EP EP09075257.7A patent/EP2113513B1/fr not_active Expired - Lifetime
- 2005-06-23 AU AU2005257484A patent/AU2005257484A1/en not_active Abandoned
- 2005-06-23 BR BRPI0512397-6A patent/BRPI0512397A/pt not_active IP Right Cessation
- 2005-06-23 JP JP2006554374A patent/JP4346650B2/ja not_active Expired - Fee Related
- 2005-06-23 EP EP05755666A patent/EP1758932A2/fr not_active Withdrawn
- 2005-06-23 MX MXPA06014206A patent/MXPA06014206A/es unknown
- 2005-06-23 WO PCT/JP2005/012021 patent/WO2006001499A2/fr not_active Ceased
- 2005-06-23 PE PE2009000637A patent/PE20091567A1/es not_active Application Discontinuation
- 2005-06-23 US US11/630,698 patent/US7625869B2/en not_active Expired - Fee Related
- 2005-06-23 TW TW094120917A patent/TW200607816A/zh unknown
- 2005-06-23 CN CN200910225195A patent/CN101845091A/zh active Pending
- 2005-06-23 AR ARP050102591A patent/AR049938A1/es unknown
- 2005-06-23 CN CN200910225194A patent/CN101863971A/zh active Pending
2006
- 2006-11-27 IL IL179640A patent/IL179640A0/en unknown
- 2006-12-21 NO NO20065957A patent/NO20065957L/no not_active Application Discontinuation
- 2006-12-22 CR CR8828A patent/CR8828A/es not_active Application Discontinuation
- 2006-12-28 MA MA29567A patent/MA28903B1/fr unknown
2008
- 2008-09-25 JP JP2008245073A patent/JP4654284B2/ja not_active Expired - Fee Related
- 2008-10-01 US US12/286,671 patent/US8778871B2/en active Active
- 2008-12-15 CL CL2008003730A patent/CL2008003730A1/es unknown
2009
- 2009-06-01 JP JP2009132363A patent/JP2009227687A/ja active Pending

Also Published As

Publication number	Publication date
EP2113513A3 (fr)	2010-11-03
PE20091567A1 (es)	2009-11-03
IL179640A0 (en)	2007-05-15
EP2113513A2 (fr)	2009-11-04
SG153865A1 (en)	2009-07-29
JP4346650B2 (ja)	2009-10-21
WO2006001499A2 (fr)	2006-01-05
AR049938A1 (es)	2006-09-13
JP2008506632A (ja)	2008-03-06
US8778871B2 (en)	2014-07-15
BRPI0512397A (pt)	2008-03-04
WO2006001499A3 (fr)	2006-03-02
CA2571420A1 (fr)	2006-01-05
MXPA06014206A (es)	2007-02-14
CN101863971A (zh)	2010-10-20
RU2006145886A (ru)	2008-06-27
EP2113513B1 (fr)	2016-05-18
CN101845091A (zh)	2010-09-29
MA28903B1 (fr)	2007-10-01
US7625869B2 (en)	2009-12-01
NO20065957L (no)	2007-01-25
EP1758932A2 (fr)	2007-03-07
US20080312155A1 (en)	2008-12-18
JP4654284B2 (ja)	2011-03-16
JP2009227687A (ja)	2009-10-08
CR8828A (es)	2007-07-19
TW200607816A (en)	2006-03-01
AU2005257484A1 (en)	2006-01-05
JP2009024028A (ja)	2009-02-05
PE20060371A1 (es)	2006-06-15
NZ552029A (en)	2009-01-31
US20090298765A1 (en)	2009-12-03

Publication	Publication Date	Title
CL2008003730A1 (es)	2009-05-04	Derivado de metastina ; profarmaco de dicho derivado; producto farmaceutico de dicho derivado; uso de dicho derivado para tratar metastasis de cancer o crecimiento del cancer.
CY1125550T1 (el)	2026-02-25	Ορισμενες τριαζολοπυραζινες, συνθεσεις αυτων και μεθοδοι για τη χρηση αυτων
CL2011000124A1 (es)	2011-05-06	Compuestos derivados de 3-aril-4-heterociclil-pirazoles, inhibidores de proteina quinasa b-raf; metodo de inhibicion in vitro de la proteina quinasa b-raf; composicion farmaceutica; producto de combinacion farmaceutica; y su uso para el tratamiento del cancer.
CL2008002243A1 (es)	2009-08-21	Compuestos derivados de 2-pirazolamino-1,3,5-triazina, inhibidores de kinasa jak; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento del cancer.
BRPI0510177B8 (pt)	2021-05-25	composto, composição farmacêutica e uso do mesmo
CY1116929T1 (el)	2017-04-05	Παραγωγα πυρρολο[2,3-d]πυριμιδινης ως αναστολεις πρωτεϊνικης κινασης β
EA201001143A1 (ru)	2011-02-28	Активаторы прокаспаз "исполнителей" 3, 6 и 7
WO2006123113A3 (fr)	2007-01-04	Composes chimiques
ECSP088561A (es)	2008-07-30	Derivados de pirimidinil-aril-urea que son inhibidores de fgf
NZ577916A (en)	2012-11-30	Cyclopamine analogs
MX2009008798A (es)	2009-08-24	Derivados de iminipiridina y sus usos como microbicidas.
DK1853602T3 (da)	2010-09-20	Kemiske forbindelser
CY1108275T1 (el)	2014-02-12	Χημικες ενωσεις
BRPI0610359B8 (pt)	2021-05-25	compostos de diaril-hidantoína, suas composições farmacêuticas e sais farmaceuticamente aceitáveis
CL2011003082A1 (es)	2012-06-08	Compuestos derivados de [1,2,4]triazolo[1,5-a]piridina, inhibidores de jak2 o fak; composiciones farmaceuticas que los comprenden; y su uso para el tratamiento de una enfermedad hiperproliferativa.
CL2008000020A1 (es)	2009-01-23	Compuestos derivados de 2,4-dianilinopirimidinas sustituidas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y tumores malignos.
MY149512A (en)	2013-09-13	Pyrazolylaminopyridine derivatives useful as kinase inhibitors
UY32882A (es)	2011-04-29	(heteroarilmetil) tiohidantoínas sustituidas
EA200801362A1 (ru)	2009-02-27	Пиримидинил бензотиофеновые соединения
EA200801428A1 (ru)	2008-10-30	Производные пиридиазинона для лечения опухолей
CL2007002382A1 (es)	2008-01-18	Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento del cancer a la piel.
CL2008000021A1 (es)	2009-03-27	Compuestos derivados de 2,4-dianilinopirimidinas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y cancer.
EA201100126A1 (ru)	2011-08-30	Нафтиридиноны в качестве ингибиторов протеинкиназ
EP4438127A3 (fr)	2024-12-25	Inhibition de la protéine associée à l'ataxie télangiectasie et à rad3 (atr)
EA201170344A1 (ru)	2011-08-30	Азаиндольные ингибиторы iap